Homozygous mutations in genes encoding HFE, transferrin receptor 2 and hemojuvelin (HJV) can result decreased hepcidin expression and the development of hemochromatosis, indicating that these proteins act as positive regulators of hepcidin synthesis. The gene discussed is HAMP; the disease is hemochromatosis type 1.